Status:
COMPLETED
Study of WPV01 in Healthy Subjects
Lead Sponsor:
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
Conditions:
Healthy Participants
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WPV01 and WPV01 Co-administrated With Ritonavir in Healthy Adult Subjects.
Eligibility Criteria
Inclusion
- Subjects signed an informed consent form with full understanding of the test content, procedure and possible adverse effects
- Chinese healthy male or female subjects between aged from 18 to 45 years
- Subjects must agree to comply with the contraceptive requirements during the trial and for 3 months after the last dose
- Body weight ≥ 50 kg for men and ≥ 45 kg for women and body mass index in the range of 18.0 \~ 28.0 kg/m2 (including 18.0 and 28.0)
- Subjects must be willing to understand and comply with study procedures and limitations, have the ability to complete the trial as planned, and be able to communicate effectively with the investigator
Exclusion
- Participants who have special dietary requirements and cannot abide by the provided food
- Pregnant or lactating women; Women who have pregnancy plan 1 month before trail, during trail or within 3 months after last dose; Women with positive serum pregnancy tests at screening or baseline
- Participants who have evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic disease
- Participants who have history of any other acute or chronic illness
- Participants who have known allergy to any ingredient in the study treatment drug
- Participants who are judged by the investigator to be unsuitable to participate in this study
Key Trial Info
Start Date :
October 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 26 2023
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT06205329
Start Date
October 3 2022
End Date
July 26 2023
Last Update
June 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shulan(Hangzhou) Hospital
Hangzhou, China